Loading data...
Setsurotech Co., Ltd.
President and CEO
Shinichiro Takezawa
New Service: Achieve long-term stable expression and increased antibody production at low cost by introducing multiple copies into the safe harbor.
Recent News & PR
Summary
Message to Participants
Detailed Information
Setsurotech Co., Ltd. is a biotechnology company that provides genome-edited mice and CHO cell production services. We offer customized mice for researchers with short delivery times and low costs, supporting antibody production and genetic research.
Unfair Advantage & Strengths
N/A
Competitors
N/A
Company Profile
事業カテゴリ
DeepTech, Healthcare / Biotech
本社所在地
Tokushima, Tokushima, Japan
設立日
2017/2/22
資本金
1億円
Employee Count
30
Industry Outlook & Trends for Setsurotech Co., Ltd.
Driven by aging populations and rising healthcare costs, the healthcare and biotech market where Setsurotech Co., Ltd. operates is growing globally. Telemedicine, digital health via wearables, AI-driven drug discovery, and gene therapy are advancing rapidly. The industry is shifting from treatment to prevention, increasing demand for highly personalized health solutions like those developed by Setsurotech Co., Ltd..
🔒
VPO Investor Pro Features
You are viewing a basic startup profile. Create a free account to access the dashboard. You can also upgrade to the "Investor Pro" plan to unlock full access to the following premium databases and features:
🎬
Elevator & Full Pitch Video
Watch full presentations with English/Japanese subtitles.
📊
AI Quick Report & Valuation
Get AI-driven assessment scores on market, product, and traction.
📅
Priority Challenges & Hiring
Access core corporate bottlenecks and current hiring plans.
📝
Full Transcripts
Read full pitch dialogue in both English and Japanese.
📈
Financials & Exit Strategy
Unlock IPO/M&A timelines and debt/equity plans.
👥
Advisors & Key Members
View internal team details and advisory board configurations.